intravitreal, VEGF Therapy, macula

CLASSIFIEDS

Find the job that’s right for you. PhysiciansJobsPlus allows you to post your resume, receive relevant ophthalmology open position alerts via email and apply for positions online.

Cover Image Not Available

August 2004

Features

AMD Treatment Pipeline

Peer-reviewed articles on investigational therapies and a look at how they will affect your practice.

Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration
By:  Stephan Michels, M.D.; Philip J. Rosenfeld, M.D., PhD.

Pegaptanib Sodium Therapy for Exudative Age-Related Macular Degeneration
By:  Lawrence J. Singerman, M.D., F.A.C.S.; Joan H. Hornik, A.B.

Will the AMD Therapies Now in Clinical Trials Deliver What They Promise?
By:  Kay T. Adams
Two specialists discuss the possible impact on practice management and what we still need to know about the new drugs.

Intravitreal Steroid Injections for Macular Edema: Way of the Future?
By:  Sophie J. Bakri, M.D.; Peter K. Kaiser, M.D.

Intravitreal Injections: A Coding and Reimbursement Review
By:  Kevin J. Corcoran, C.O.E., C.P.C., F.N.A.O.
The number of claims your practice files will increase as new therapeutic substances become available.

Do the Advantages of 25-Gauge Vitrectomy Outweigh the Disadvantages?
By:  Carl C. Awh, M.D.
One surgeon explains why his answer is yes.

The Economics of Visudyne

The latest cost and reimbursement changes were a net positive, but attention to efficiency remains crucial.

Departments

Upfront
By:  Jason S. Slakter, M.D.
A New Forum for Retina Specialists

Insights from Industry
By:  Flemming Orsnkov, M.D., M.P.H.; Cynthia Hogan
Diabetic Retinopathy: a Formidable Challenge

Imaging
Assessing RPE Function with Autofluorescence




AWS-#2